X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1091) 1091
Publication (64) 64
Book Review (9) 9
Magazine Article (4) 4
Newspaper Article (3) 3
Book Chapter (2) 2
Newsletter (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (994) 994
female (602) 602
male (585) 585
chlorambucil - adverse effects (514) 514
middle aged (472) 472
chlorambucil - therapeutic use (415) 415
adult (399) 399
aged (386) 386
chlorambucil (336) 336
chlorambucil - administration & dosage (270) 270
antineoplastic combined chemotherapy protocols - therapeutic use (218) 218
index medicus (207) 207
leukemia, lymphocytic, chronic, b-cell - drug therapy (183) 183
antineoplastic combined chemotherapy protocols - adverse effects (182) 182
oncology (179) 179
cyclophosphamide - adverse effects (162) 162
cyclophosphamide (157) 157
treatment outcome (155) 155
adolescent (144) 144
hematology (142) 142
rituximab (138) 138
cyclophosphamide - therapeutic use (130) 130
therapy (122) 122
cyclophosphamide - administration & dosage (121) 121
immunosuppressive agents - therapeutic use (121) 121
antineoplastic agents - adverse effects (117) 117
follow-up studies (113) 113
child (107) 107
chronic lymphocytic leukemia (103) 103
immunosuppressive agents - adverse effects (103) 103
drug therapy, combination (102) 102
chemotherapy (96) 96
time factors (96) 96
aged, 80 and over (88) 88
cancer (88) 88
antineoplastic agents - therapeutic use (85) 85
remission induction (84) 84
drug administration schedule (83) 83
nephrotic syndrome (79) 79
prognosis (79) 79
prednisone - administration & dosage (78) 78
fludarabine (77) 77
nephrotic syndrome - drug therapy (77) 77
prednisone - therapeutic use (75) 75
clinical trials as topic (69) 69
arthritis, rheumatoid - drug therapy (68) 68
child, preschool (68) 68
azathioprine - therapeutic use (67) 67
leukemia (67) 67
medicine, general & internal (67) 67
animals (66) 66
glomerulonephritis, membranous - drug therapy (66) 66
disease-free survival (63) 63
hodgkin disease - drug therapy (63) 63
urology & nephrology (63) 63
vidarabine - analogs & derivatives (63) 63
prednisolone - administration & dosage (62) 62
recurrence (61) 61
prednisone - adverse effects (59) 59
azathioprine - adverse effects (57) 57
doxorubicin - administration & dosage (56) 56
retrospective studies (56) 56
antineoplastic agents, alkylating - adverse effects (55) 55
risk factors (54) 54
dose-response relationship, drug (53) 53
methotrexate - therapeutic use (52) 52
care and treatment (50) 50
leukemia, lymphocytic, chronic, b-cell - mortality (50) 50
methylprednisolone (50) 50
prednisone (50) 50
combined modality therapy (49) 49
leukemia, lymphoid - drug therapy (49) 49
lymphoma, non-hodgkin - drug therapy (49) 49
neoplasm staging (49) 49
trial (49) 49
lymphoma (48) 48
prednisolone - therapeutic use (48) 48
vincristine - administration & dosage (48) 48
prednisolone - adverse effects (47) 47
vinblastine - administration & dosage (47) 47
cll (45) 45
drug therapy (45) 45
methotrexate - adverse effects (45) 45
survival (45) 45
pharmacology & pharmacy (43) 43
survival rate (43) 43
vidarabine - administration & dosage (42) 42
biopsy (41) 41
drug evaluation (41) 41
antineoplastic agents - administration & dosage (40) 40
bleomycin - administration & dosage (40) 40
cyclosporine (40) 40
leukopenia - chemically induced (40) 40
antineoplastic combined chemotherapy protocols - administration & dosage (39) 39
vidarabine - adverse effects (39) 39
antineoplastic agents, alkylating - therapeutic use (38) 38
chlorambucil - analogs & derivatives (38) 38
leukemia - chemically induced (38) 38
procarbazine - administration & dosage (38) 38
prospective studies (38) 38
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (916) 916
French (74) 74
German (47) 47
Spanish (15) 15
Russian (14) 14
Italian (10) 10
Japanese (8) 8
Polish (4) 4
Norwegian (3) 3
Portuguese (3) 3
Chinese (2) 2
Croatian (1) 1
Finnish (1) 1
Hungarian (1) 1
Korean (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 25, pp. 2425 - 2437
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9980, pp. 1873 - 1883
Summary Background Treatment for patients with chronic lymphocytic leukaemia who are elderly or who have comorbidities is challenging because fludarabine-based... 
Internal Medicine | BENDAMUSTINE | 1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | CLL | CYCLOPHOSPHAMIDE | CHEMOIMMUNOTHERAPY | RITUXIMAB | MONOCLONAL-ANTIBODIES | ELDERLY-PATIENTS | FLUDARABINE | HUMAN CD20 | Age Distribution | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Chlorambucil - adverse effects | Prospective Studies | Chlorambucil - therapeutic use | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents, Alkylating - administration & dosage | Aged, 80 and over | Adult | Female | Chlorambucil - administration & dosage | Drug Administration Schedule | Kaplan-Meier Estimate | Treatment Outcome | Antineoplastic Agents, Alkylating - therapeutic use | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sex Distribution | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Antineoplastic Agents, Alkylating - adverse effects | Chlorambucil | Medical colleges | Hospitals | Comorbidity | United Kingdom | Product development | India | Medical research | Flow cytometry | Immunoglobulins | Medical imaging | Laboratories | Cytotoxicity | Infections | Ovarian cancer | Bone marrow | Drug dosages | Age | Binding sites | Geriatrics | Neutropenia
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2014, Volume 370, Issue 12, pp. 1101 - 1110
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1331 - 1344
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2011, Volume 29, Issue 26, pp. 3559 - 3566
Journal Article
Journal Article
Journal Article
Blood, ISSN 0006-4971, 10/2001, Volume 98, Issue 8, pp. 2319 - 2325
To comparatively assess first-line treatment with fludarabine and 2 anthracycline-containing regimens, namely CAP (cyclophosphamide, doxorubicin plus... 
AGENT | PHOSPHATE | TRIAL | PREDNISONE | INFECTIONS | CLL | THERAPY | TERM FOLLOW-UP | HEMATOLOGY | CHLORAMBUCIL | LYMPHOID MALIGNANCIES | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Hospitalization - statistics & numerical data | Male | Cyclophosphamide - adverse effects | Cisplatin - administration & dosage | Vidarabine Phosphate - analogs & derivatives | Time Factors | Phosphoramide Mustards - administration & dosage | Phosphoramide Mustards - adverse effects | Vidarabine Phosphate - adverse effects | Vincristine - administration & dosage | Female | Vidarabine Phosphate - therapeutic use | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Prednisone - adverse effects | Proportional Hazards Models | Survival Rate | Disease Progression | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Antimetabolites, Antineoplastic - therapeutic use | Sample Size | Antimetabolites, Antineoplastic - adverse effects | Cisplatin - adverse effects | Lymphocyte Count | Vincristine - adverse effects | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Neoplasm Staging | Doxorubicin - adverse effects
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2009, Volume 27, Issue 26, pp. 4378 - 4384
Journal Article
Journal Article